Robinhood Markets, Inc.’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
Robinhood Markets, Inc.'s CRSP Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in CRISPR Therapeutics (CRSP) in Q3 2026: 222 shares worth $12.3K. The stake represents ﹤0.01% of the portfolio and ranks #321 among its holdings.
503 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.
- Robinhood Markets, Inc. held 222 shares of CRISPR Therapeutics worth $12.3K as of Q3 2026.
- CRISPR Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
- CRISPR Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #321 holding.
- 503 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.